Literature DB >> 11122216

The relationship of eosinophil granule proteins to ions in the sputum of patients with cystic fibrosis.

G Halmerbauer1, S Arri, M Schierl, E Strauch, D Y Koller.   

Abstract

Increased sputum levels of eosinophil granule proteins have been reported despite normal eosinophil numbers in peripheral blood and in the lung in cystic fibrosis (CF). Mechanisms of eosinophil priming and activation are still unclear in CF. In the present study we investigated whether ion concentrations in the sputa of CF patients are related to eosinophil activity. We assessed concentrations of eosinophil cationic protein (ECP), eosinophil protein X (EPX), major basic protein (MBP) and ions (Na+, Cl-, Ca2+, Mg2+) in sputum samples of 29 children with CF as well as in 10 controls with bronchial asthma. Patients with CF demonstrated significantly higher levels of ECP, Na+, Cl- and Ca2+ levels than asthmatics (P < 0.04, P < 0.0001, P < 0.0001, P < 0.02). No differences were seen between concentrations of EPX and Mg2+ in the two groups. In CF, eosinophil granule proteins correlated significantly with Ca2+ and Mg2+ concentrations (ECP, P < 0.0001, r = 0.65, P < 0.0001, r = 0.66; MBP, P < 0.03, r = 0.41, P < 0.03, r = 0.42), furthermore inversely with Cl- concentrations (ECP, P < 0. 0003, r = - 0.63; EPX, P < 0.02, r = - 0.45; MBP, P < 0.03, r = - 0. 41) but not with Na+ levels. ECP, Na+ and Cl- were also correlated with lung function variables (FVC, P < 0.04, r = - 0.38, P < 0.02, r = 0.44, P < 0.03, r = 0.41; FEV1, P < 0.007, r = - 0.49, P < 0.006, r = 0.5, P < 0.008, r = 0.48; MEF50, P < 0.003, r = - 0.54, NS, P < 0.03, r = 0.42; MEF25, P < 0.039, r = - 0.4, P < 0.005, r = 0.51, P < 0.05, r = 0.37). Our results demonstrated a significant relationship of eosinophil degranulation and ions in CF, indicating that ion composition in CF sputa may be at least partly be responsible for high levels of eosinophil products despite low eosinophil numbers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122216     DOI: 10.1046/j.1365-2222.2000.00988.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

1.  The Pseudomonas aeruginosa PAO1 Two-Component Regulator CarSR Regulates Calcium Homeostasis and Calcium-Induced Virulence Factor Production through Its Regulatory Targets CarO and CarP.

Authors:  Manita Guragain; Michelle M King; Kerry S Williamson; Ailyn C Pérez-Osorio; Tatsuya Akiyama; Sharmily Khanam; Marianna A Patrauchan; Michael J Franklin
Journal:  J Bacteriol       Date:  2016-01-11       Impact factor: 3.490

Review 2.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

3.  Calcium-Regulated Protein CarP Responds to Multiple Host Signals and Mediates Regulation of Pseudomonas aeruginosa Virulence by Calcium.

Authors:  Michelle King; Aya Kubo; Leah Kafer; Reygan Braga; Daniel McLeod; Sharmily Khanam; Tyrrell Conway; Marianna A Patrauchan
Journal:  Appl Environ Microbiol       Date:  2021-04-27       Impact factor: 4.792

4.  Calcium homeostasis in Pseudomonas aeruginosa requires multiple transporters and modulates swarming motility.

Authors:  Manita Guragain; Dirk L Lenaburg; Frank S Moore; Ian Reutlinger; Marianna A Patrauchan
Journal:  Cell Calcium       Date:  2013-09-08       Impact factor: 6.817

5.  Antimicrobial peptide therapeutics for cystic fibrosis.

Authors:  Lijuan Zhang; Jody Parente; Scott M Harris; Donald E Woods; Robert E W Hancock; Timothy J Falla
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis.

Authors:  N N Sanders; H Franckx; K De Boeck; J Haustraete; S C De Smedt; J Demeester
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 7.  The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions.

Authors:  Bee Ha Gan; Josephine Gaynord; Sam M Rowe; Tomas Deingruber; David R Spring
Journal:  Chem Soc Rev       Date:  2021-07-05       Impact factor: 54.564

8.  Sputum analysis in diagnosis and management of obstructive airway diseases.

Authors:  Paige Lacy; Jennifer L Lee; Dilini Vethanayagam
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

9.  A Pseudomonas aeruginosa EF-hand protein, EfhP (PA4107), modulates stress responses and virulence at high calcium concentration.

Authors:  Svetlana A Sarkisova; Shalaka R Lotlikar; Manita Guragain; Ryan Kubat; John Cloud; Michael J Franklin; Marianna A Patrauchan
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

10.  Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.

Authors:  Rosa van Mansfeld; Mark de Been; Fernanda Paganelli; Lei Yang; Marc Bonten; Rob Willems
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.